Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation
|
journal
|
May 2017 |
Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G
|
journal
|
November 2017 |
Structure-Guided Analysis of the Human APOBEC3-HIV Restrictome
|
journal
|
May 2014 |
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
|
journal
|
December 2008 |
Computational Model and Dynamics of Monomeric Full-Length APOBEC3G
|
journal
|
October 2017 |
Complementary function of the two catalytic domains of APOBEC3G
|
journal
|
March 2005 |
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
|
journal
|
December 2011 |
Crystal structures of APOBEC3G N-domain alone and its complex with DNA
|
journal
|
August 2016 |
Functional Analysis and Structural Modeling of Human APOBEC3G Reveal the Role of Evolutionarily Conserved Elements in the Inhibition of Human Immunodeficiency Virus Type 1 Infection and Alu Transposition
|
journal
|
September 2009 |
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
|
journal
|
March 2018 |
Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA
|
journal
|
January 2018 |
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo
|
journal
|
May 2005 |
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
|
journal
|
December 2015 |
Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All
|
journal
|
March 2014 |
APOBEC3G Oligomerization Is Associated with the Inhibition of Both Alu and LINE-1 Retrotransposition
|
journal
|
December 2013 |
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
|
journal
|
April 2006 |
Retroviral restriction by APOBEC proteins
|
journal
|
November 2004 |
Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses
|
journal
|
June 2013 |
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
|
journal
|
November 2003 |
A quantitative assay for HIV DNA integration in vivo
|
journal
|
May 2001 |
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
|
journal
|
January 2005 |
From The Cover: A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
|
journal
|
March 2004 |
The role of DNA shape in protein–DNA recognition
|
journal
|
October 2009 |
Nanoscale Characterization of Interaction of APOBEC3G with RNA
|
journal
|
March 2017 |
T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction
|
journal
|
December 2011 |
Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA
|
journal
|
July 2018 |
RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1
|
journal
|
March 2009 |
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition
|
journal
|
October 2006 |
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities
|
journal
|
March 2005 |
1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure
|
journal
|
June 2016 |
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif
|
journal
|
August 2014 |
Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands
|
journal
|
August 2018 |
Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
|
journal
|
November 2018 |
Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H
|
journal
|
February 2007 |
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications
|
journal
|
October 2008 |
Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis
|
journal
|
December 2009 |
Promiscuous RNA Binding Ensures Effective Encapsidation of APOBEC3 Proteins by HIV-1
|
journal
|
January 2015 |
Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G
|
journal
|
March 2010 |
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA
|
journal
|
June 2018 |
From The Cover: A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)
|
journal
|
February 2004 |
APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA
|
journal
|
October 2017 |
The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements
|
journal
|
April 2008 |
Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect
|
journal
|
June 2006 |
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
|
journal
|
October 2007 |
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
|
journal
|
May 2003 |
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
|
journal
|
July 2002 |
A Hydrodynamic Analysis of APOBEC3G Reveals a Monomer−Dimer−Tetramer Self-Association That Has Implications for Anti-HIV Function
|
journal
|
November 2009 |
The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism
|
journal
|
January 2018 |
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|
journal
|
April 1996 |
DNA Deamination Mediates Innate Immunity to Retroviral Infection
|
journal
|
February 2004 |
Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation
|
journal
|
June 2017 |
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
|
text
|
January 2021 |
The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism
|
dataset
|
January 2017 |
DNA Deamination Mediates Innate Immunity to Retroviral Infection
|
journal
|
June 2003 |
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
|
journal
|
July 2003 |
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G
|
journal
|
May 2015 |
A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action
|
journal
|
February 2004 |
Single-stranded DNA Scanning and Deamination by APOBEC3G Cytidine Deaminase at Single Molecule Resolution
|
journal
|
February 2012 |
Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs
|
journal
|
June 2004 |
APOBEC3G Subunits Self-associate via the C-terminal Deaminase Domain
|
journal
|
October 2008 |
Mutational Alteration of Human Immunodeficiency Virus Type 1 Vif Allows for Functional Interaction with Nonhuman Primate APOBEC3G
|
journal
|
June 2006 |
Association of Potent Human Antiviral Cytidine Deaminases with 7SL RNA and Viral RNP in HIV-1 Virions
|
journal
|
October 2010 |
Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation
|
journal
|
January 2007 |